SCHEMBL23052979

SCHEMBL23052979

CC(=O)c1cc(Oc2ccccc2)cc(Oc2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.58
▸ MAPT P10636 3/20 0.57
▸ HPGD P15428 1/20 0.57
▸ RAB9A P51151 1/20 0.57
▸ HDAC8 Q9BY41 1/20 0.51
▸ MAOB P27338 1/20 0.51
▸ PARP10 Q53GL7 1/20 0.50
▸ CRHBP P24387 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ CRHR2 Q13324 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ SRD5A2 P31213 1/20 0.48
▸ LTA4H P09960 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ RECQL P46063 1/20 0.47
▸ TLR4 O00206 1/20 0.47
▸ TLR2 O60603 1/20 0.47
▸ ERCC5 P28715 1/20 0.47
▸ FEN1 P39748 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12604608 0.89 AKR1C3 (0.51) AKR1C3MAPTHPGDRAB9AHDAC8
SCHEMBL2350424 0.86 AKR1C3 (0.72) AKR1C3MAPTHPGDRAB9AHDAC8
SCHEMBL167640 0.83 RAB9A (0.83) MAPTHPGDRAB9AMAOBPARP10
SCHEMBL5747830 0.83 AKR1C3 (0.74) AKR1C3HDAC8PARP10MEN1KMT2A
SCHEMBL3439666 0.82 MAPT (0.61) MAPTHPGDRAB9AMAOBMEN1
SCHEMBL12742894 0.81 GCK (0.61) —
SCHEMBL22210569 0.81 TSHR (0.59) AKR1C3MAPTHPGDRAB9AHDAC8
SCHEMBL12220509 0.81 MAPT (0.59) MAPTHPGDRAB9APARP10MEN1
Diphenylether SCHEMBL28412058 0.80 LTA4H (0.67) AKR1C3MAPTHPGDRAB9APARP10
Diphenylether SCHEMBL29175285 0.80 LTA4H (0.67) AKR1C3MAPTHPGDRAB9APARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220393118-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF CHE, CHI MING (CN) 2022-12-08 — — US disclosed
WO-2021036978-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF CHE CHI MING (CN) 2021-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220393118-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF PDCD2L, TTL, TTLL12 AKR1C3 3054/4885MAPT 20/4885HPGD 4495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback